Global Genetic Disorders Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Genetic Disorders Drug

• 1.1 Definition of Genetic Disorders Drug
• 1.2 Genetic Disorders Drug Segment by Type
  • 1.2.1 Global Genetic Disorders Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Cystic Fibrosis (CF)
  • 1.2.3 Duchenne Muscular Dystrophy (DMD)
  • 1.2.4 Lysosomal Storage Disease (LSD)
  • 1.2.5 Paroxysmal Nocturnal Hemoglobinuria (PNH)
• 1.3 Genetic Disorders Drug Segment by Applications
  • 1.3.1 Global Genetic Disorders Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
• 1.4 Global Genetic Disorders Drug Overall Market
  • 1.4.1 Global Genetic Disorders Drug Revenue (2014-2025)
  • 1.4.2 Global Genetic Disorders Drug Production (2014-2025)
  • 1.4.3 North America Genetic Disorders Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Genetic Disorders Drug Status and Prospect (2014-2025)
  • 1.4.5 China Genetic Disorders Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Genetic Disorders Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Genetic Disorders Drug Status and Prospect (2014-2025)
  • 1.4.8 India Genetic Disorders Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Genetic Disorders Drug
• 2.3 Manufacturing Process Analysis of Genetic Disorders Drug
• 2.4 Industry Chain Structure of Genetic Disorders Drug

3 Development and Manufacturing Plants Analysis of Genetic Disorders Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Genetic Disorders Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Genetic Disorders Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Genetic Disorders Drug Production and Capacity Analysis
• 4.2 Genetic Disorders Drug Revenue Analysis
• 4.3 Genetic Disorders Drug Price Analysis
• 4.4 Market Concentration Degree

5 Genetic Disorders Drug Regional Market Analysis

• 5.1 Genetic Disorders Drug Production by Regions
  • 5.1.1 Global Genetic Disorders Drug Production by Regions
  • 5.1.2 Global Genetic Disorders Drug Revenue by Regions
• 5.2 Genetic Disorders Drug Consumption by Regions
• 5.3 North America Genetic Disorders Drug Market Analysis
  • 5.3.1 North America Genetic Disorders Drug Production
  • 5.3.2 North America Genetic Disorders Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Genetic Disorders Drug Import and Export
• 5.4 Europe Genetic Disorders Drug Market Analysis
  • 5.4.1 Europe Genetic Disorders Drug Production
  • 5.4.2 Europe Genetic Disorders Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Genetic Disorders Drug Import and Export
• 5.5 China Genetic Disorders Drug Market Analysis
  • 5.5.1 China Genetic Disorders Drug Production
  • 5.5.2 China Genetic Disorders Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Genetic Disorders Drug Import and Export
• 5.6 Japan Genetic Disorders Drug Market Analysis
  • 5.6.1 Japan Genetic Disorders Drug Production
  • 5.6.2 Japan Genetic Disorders Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Genetic Disorders Drug Import and Export
• 5.7 Southeast Asia Genetic Disorders Drug Market Analysis
  • 5.7.1 Southeast Asia Genetic Disorders Drug Production
  • 5.7.2 Southeast Asia Genetic Disorders Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Genetic Disorders Drug Import and Export
• 5.8 India Genetic Disorders Drug Market Analysis
  • 5.8.1 India Genetic Disorders Drug Production
  • 5.8.2 India Genetic Disorders Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Genetic Disorders Drug Import and Export

6 Genetic Disorders Drug Segment Market Analysis (by Type)

• 6.1 Global Genetic Disorders Drug Production by Type
• 6.2 Global Genetic Disorders Drug Revenue by Type
• 6.3 Genetic Disorders Drug Price by Type

7 Genetic Disorders Drug Segment Market Analysis (by Application)

• 7.1 Global Genetic Disorders Drug Consumption by Application
• 7.2 Global Genetic Disorders Drug Consumption Market Share by Application (2014-2019)

8 Genetic Disorders Drug Major Manufacturers Analysis

• 8.1 Sanofi
  • 8.1.1 Sanofi Genetic Disorders Drug Production Sites and Area Served
  • 8.1.2 Sanofi Product Introduction, Application and Specification
  • 8.1.3 Sanofi Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Vertex
  • 8.2.1 Vertex Genetic Disorders Drug Production Sites and Area Served
  • 8.2.2 Vertex Product Introduction, Application and Specification
  • 8.2.3 Vertex Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Shire
  • 8.3.1 Shire Genetic Disorders Drug Production Sites and Area Served
  • 8.3.2 Shire Product Introduction, Application and Specification
  • 8.3.3 Shire Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Amgen
  • 8.4.1 Amgen Genetic Disorders Drug Production Sites and Area Served
  • 8.4.2 Amgen Product Introduction, Application and Specification
  • 8.4.3 Amgen Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 GW Pharmaceuticals
  • 8.5.1 GW Pharmaceuticals Genetic Disorders Drug Production Sites and Area Served
  • 8.5.2 GW Pharmaceuticals Product Introduction, Application and Specification
  • 8.5.3 GW Pharmaceuticals Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Pfizer
  • 8.6.1 Pfizer Genetic Disorders Drug Production Sites and Area Served
  • 8.6.2 Pfizer Product Introduction, Application and Specification
  • 8.6.3 Pfizer Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 BioMarin
  • 8.7.1 BioMarin Genetic Disorders Drug Production Sites and Area Served
  • 8.7.2 BioMarin Product Introduction, Application and Specification
  • 8.7.3 BioMarin Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Sarepta
  • 8.8.1 Sarepta Genetic Disorders Drug Production Sites and Area Served
  • 8.8.2 Sarepta Product Introduction, Application and Specification
  • 8.8.3 Sarepta Genetic Disorders Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Genetic Disorders Drug Market

• 9.1 Global Genetic Disorders Drug Market Trend Analysis
  • 9.1.1 Global Genetic Disorders Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Genetic Disorders Drug Regional Market Trend
  • 9.2.1 North America Genetic Disorders Drug Forecast 2019-2025
  • 9.2.2 Europe Genetic Disorders Drug Forecast 2019-2025
  • 9.2.3 China Genetic Disorders Drug Forecast 2019-2025
  • 9.2.4 Japan Genetic Disorders Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Genetic Disorders Drug Forecast 2019-2025
  • 9.2.6 India Genetic Disorders Drug Forecast 2019-2025
• 9.3 Genetic Disorders Drug Market Trend (Product Type)
• 9.4 Genetic Disorders Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Genetic Disorders Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List